In fact, by understanding that insulin mediates the process of the pathology of diabetes via obesity, the primary target of diabetes prevention in high-risk communities should be targeting insulin and other inflammatory biomarkers, allowing for early diagnosis and treatment. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.